“Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s726, https://doi.org/10.25251/mjfdzc48.